Literature DB >> 16400516

Methods to assess in vitro drug release from injectable polymeric particulate systems.

Susan S D'Souza1, Patrick P DeLuca.   

Abstract

This review provides a compilation of the methods used to study real-time (37 degrees C) drug release from parenteral microparticulate drug delivery systems administered via the subcutaneous or intramuscular route. Current methods fall into three broad categories, viz., sample and separate, flow-through cell, and dialysis techniques. The principle of the specific method employed along with the advantages and disadvantages are described. With the "sample and separate" technique, drug-loaded microparticles are introduced into a vessel, and release is monitored over time by analysis of supernatant or drug remaining in the microspheres. In the "flow-through cell" technique, media is continuously circulated through a column containing drug-loaded microparticles followed by analysis of the eluent. The "dialysis" method achieves a physical separation of the drug-loaded microparticles from the release media by use of a membrane, which allows for sampling without interference of the microspheres. With all these methods, the setup and sampling techniques seem to influence in vitro release; the results are discussed in detail, and criteria to aid in selection of a method are stated. Attempts to establish in vitro-in vivo correlation for these injectable dosage forms are also discussed. It would be prudent to have an in vitro test method for microparticles that satisfies compendial and regulatory requirements, is user friendly, robust, and reproducible, and can be used for quality-control purposes at real-time and elevated temperatures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400516     DOI: 10.1007/s11095-005-9397-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  101 in total

1.  In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres.

Authors:  Byung Ho Woo; Kyu-Heum Na; Bhas A Dani; Ge Jiang; B C Thanoo; Patrick P DeLuca
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

2.  Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.

Authors:  Juan Wang; Barbara M Wang; Steven P Schwendeman
Journal:  Biomaterials       Date:  2004-05       Impact factor: 12.479

3.  Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.

Authors:  Hong Kee Kim; Tae Gwan Park
Journal:  J Control Release       Date:  2004-07-23       Impact factor: 9.776

4.  Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.

Authors:  S Takada; T Kurokawa; K Miyazaki; S Iwasa; Y Ogawa
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

5.  Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates.

Authors:  E Leo; R Cameroni; F Forni
Journal:  Int J Pharm       Date:  1999-03-25       Impact factor: 5.875

6.  Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin.

Authors:  B Ertl; P Platzer; M Wirth; F Gabor
Journal:  J Control Release       Date:  1999-09-20       Impact factor: 9.776

7.  Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres.

Authors:  Cory Berkland; Matt J Kipper; Balaji Narasimhan; Kyekyoon Kevin Kim; Daniel W Pack
Journal:  J Control Release       Date:  2004-01-08       Impact factor: 9.776

8.  The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method.

Authors:  R Bodmeier; J W McGinity
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

9.  Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms.

Authors:  C Gido; P Langguth; J Kreuter; G Winter; H Woog; E Mutschler
Journal:  Pharmazie       Date:  1993-10       Impact factor: 1.267

10.  Microparticulate formulations for the controlled release of interleukin-2.

Authors:  Tommy T Thomas; Daniel S Kohane; Audrey Wang; Robert Langer
Journal:  J Pharm Sci       Date:  2004-05       Impact factor: 3.534

View more
  50 in total

1.  PLGA erosion: solubility- or diffusion-controlled?

Authors:  Martin Körber
Journal:  Pharm Res       Date:  2010-08-03       Impact factor: 4.200

2.  Towards more realistic in vitro release measurement techniques for biodegradable microparticles.

Authors:  D Klose; N Azaroual; F Siepmann; G Vermeersch; J Siepmann
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

Review 3.  Points to consider when establishing drug product specifications for parenteral microspheres.

Authors:  Rajesh Kumar; Michael J Palmieri
Journal:  AAPS J       Date:  2009-11-17       Impact factor: 4.009

Review 4.  Critical factors influencing the in vivo performance of long-acting lipophilic solutions--impact on in vitro release method design.

Authors:  Susan Weng Larsen; Claus Larsen
Journal:  AAPS J       Date:  2009-11-06       Impact factor: 4.009

5.  Engineering cells with intracellular agent-loaded microparticles to control cell phenotype.

Authors:  James A Ankrum; Oscar R Miranda; Kelvin S Ng; Debanjan Sarkar; Chenjie Xu; Jeffrey M Karp
Journal:  Nat Protoc       Date:  2014-01-09       Impact factor: 13.491

6.  FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms.

Authors:  Cynthia K Brown; Horst Dieter Friedel; Amy R Barker; Lucinda F Buhse; Susanne Keitel; Todd L Cecil; Johannes Kraemer; J Michael Morris; Christos Reppas; Mary P Stickelmeyer; Chikako Yomota; Vinod P Shah
Journal:  AAPS PharmSciTech       Date:  2011-06-18       Impact factor: 3.246

7.  Translational studies on a ready-to-use intramuscular injection of penethamate for bovine mastitis.

Authors:  I G Tucker; R Jain; F Alawi; K Nanjan; O Bork
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

8.  Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.

Authors:  Brijeshkumar Patel; Nilesh Gupta; Fakhrul Ahsan
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-11-28       Impact factor: 2.849

9.  Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery.

Authors:  Qiaobing Xu; Michinao Hashimoto; Tram T Dang; Todd Hoare; Daniel S Kohane; George M Whitesides; Robert Langer; Daniel G Anderson
Journal:  Small       Date:  2009-07       Impact factor: 13.281

10.  5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study.

Authors:  Amir Maghsoudi; Seyed Abbas Shojaosadati; Ebrahim Vasheghani Farahani
Journal:  AAPS PharmSciTech       Date:  2008-10-11       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.